Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 16;2(9):193-9.
doi: 10.1302/2046-3758.29.2000189. Print 2013.

Trends in biological joint resurfacing

Affiliations

Trends in biological joint resurfacing

K R Myers et al. Bone Joint Res. .

Abstract

The treatment of osteochondral lesions and osteoarthritis remains an ongoing clinical challenge in orthopaedics. This review examines the current research in the fields of cartilage regeneration, osteochondral defect treatment, and biological joint resurfacing, and reports on the results of clinical and pre-clinical studies. We also report on novel treatment strategies and discuss their potential promise or pitfalls. Current focus involves the use of a scaffold providing mechanical support with the addition of chondrocytes or mesenchymal stem cells (MSCs), or the use of cell homing to differentiate the organism's own endogenous cell sources into cartilage. This method is usually performed with scaffolds that have been coated with a chemotactic agent or with structures that support the sustained release of growth factors or other chondroinductive agents. We also discuss unique methods and designs for cell homing and scaffold production, and improvements in biological joint resurfacing. There have been a number of exciting new studies and techniques developed that aim to repair or restore osteochondral lesions and to treat larger defects or the entire articular surface. The concept of a biological total joint replacement appears to have much potential. Cite this article: Bone Joint Res 2013;2:193-9.

Keywords: Biological joint resurfacing; Cartilage regeneration; Orthopaedic surgery; Regenerative medicine; Stem cells; Tissue engineering.

PubMed Disclaimer

Conflict of interest statement

ICMJE Conflict of Interest:None declared

Figures

Fig. 1
Fig. 1
Schematic of the autogenous osteochondral transplantation (AOT) procedure.
Fig. 2
Fig. 2
Diagram of the autologous chondrocyte implantation (ACI) procedure. A sample of healthy cartilage is isolated and then expanded in vitro over two to three weeks. The chondrocytes are then implanted into the defect and covered with a periosteal patch.
Fig. 3
Fig. 3
Diagram showing an example of an integrated approach to cartilage regeneration combining a scaffold structure coated with a homing molecule with local and systemic chemotactic and chondrogenic agents (MMP, matrix metalloproteinase; MSC, mesenchymal stem cell).

References

    1. Mano JF, Reis RL. Osteochondral defects: present situation and tissue engineering approaches. J Tissue Eng Regen Med 2007;1:261–273 - PubMed
    1. Swieszkowski W, Tuan BH, Kurzydlowski KJ, Hutmacher DW. Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng 2007;24:489–495 - PubMed
    1. Oldershaw RA. Cell source for the regeneration of articular cartilage: the past, the horizon and the future. Int J Exp Pathol 2012;93:389–400 - PMC - PubMed
    1. Goldring MB, Otero M, Plumb DA, et al. Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 2011;21:202–220 - PMC - PubMed
    1. Leong DJ, Hardin JA, Cobelli NJ, Sun HB. Mechanotransduction and cartilage integrity. Ann N Y Acad Sci 2011;1240:32–37 - PMC - PubMed